NCT07801131Completed
Ultrasonographic Evaluation of Talar Cartilage Thickness in Patients With Diabetic Polyneuropathy
Source: ClinicalTrials.gov · Last updated 21 Oct 2026
Brief summary (registry, in English)
This study aimed to evaluate talar cartilage thickness in individuals with diabetic polyneuropathy using ultrasonography and to compare the findings with those of healthy individuals. Diabetic polyneuropathy may cause biomechanical changes in the lower extremities, which may affect ankle joint structures. Ultrasonography, a non-invasive and accessible imaging method, was used to measure cartilage thickness. The study included individuals with type 2 diabetes mellitus and electromyography-confirmed diabetic polyneuropathy, as well as sex-matched healthy control subjects. The results are expected to improve understanding of musculoskeletal involvement in diabetic polyneuropathy and to support early detection of joint changes.
- Status (registry)
- Completed
- Study type
- Observational
- Enrollment
- 30 (actual)
- First submitted
- 26 Aug 2026
- Start date
- 1 Jul 2025
- Primary completion date
- 1 Jul 2026
- Lead sponsor
- Istanbul Physical Medicine Rehabilitation Training and Research Hospital
- Diseases
- Type 2 diabetes
- NCT number
- NCT07801131
What you commit to
- Study type: Observational
- Participants enrolled: 30
- From 1 Jul 2025 to the primary completion date, 1 Jul 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- History of trauma or surgery involving the foot or ankle
- Degenerative joint disease, rheumatologic disease or infection of the foot or ankle
- Other systemic diseases that may cause neuropathy
Other
- Local skin lesion or deformity preventing ultrasonographic assessment
Who the study is looking for
- Age 40-70 years
- Type 2 diabetes mellitus for at least 1 year
- Diabetic polyneuropathy confirmed by electromyography (EMG)
- Age 40-70 years
- No diagnosis of diabetes mellitus and fasting plasma glucose \<126 mg/dL
- No symptoms or signs of neuropathy (Michigan Neuropathy Screening Instrument)
Age in the registry: 40 years to 70 years · Sex: All · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Istanbul Physical Medicine Rehabilitation Training and Research Hospital Coordinator of this site? Confirm its status | Istanbul | Turkey (Türkiye) | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.